The SoLá Pelvic Therapy Deep Tissue Photobiomudlation System is a high-power NON ABLATIVE near-infrared laser that is marketed on-label for the the temporary relief of pelvic muscle spasm, pain, and improvement of circulation. This is the first and only transvaginal photobiomodulation system with the proven ability to deliver therapeutic doses of near-infrared energy to the muscles and organs of the pelvis (Evaluation of a novel deep tissue transvaginal near-infrared laser . Lasers Med Sci. 2021). Over 3,500 treatments have been performed without any serious adverse events or unanticipated adverse events. Most patients realize significant pain reduction within two weeks. Significant pain reductions have been consistent across multiple diagnoses associated with pelvic pain including endometriosis, IC, and hypertonic pelvic floor.
The SoLá Pelvic Therapy Deep Tissue Photobiomudlation System gathers patient-reported outcomes for each pain symptom. This data is provided graphically on the laser's screen for review with the patient. This same data is also part of an ongoing nationwide HIPAA compliant analysis providing real-world evidence to patients and their health care providers.